🌎 CoreWeave, Inc. Class A Common Stock Downgraded, Sarepta Therapeutics Downgraded, Smurfit Westrock Upgraded and more...

Ratings changes for Nebius Group, CoreWeave, Inc. Class A Common Stock, Sarepta Therapeutics, Janover, Sarepta Therapeutics, UroGen Pharma, ZenaTech and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more.  Start Your Free Trial. Unsubscribe. View My Portfolio June 16th, 2025     Retirees Are Using This Gold Strategy Before the Next Crash (ad) What if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? No gimmicks. No shady tricks. Just a powerful IRS-approved loophole that most Americans have never heard of. It's called a Self-Directed Gold IRA, and it's quietly becoming the go-to wealth protection strategy for people who see the writing on the wall. When you take the next step, you could qualify for up to $10,000 in FREE GOLD & SILVER with your purchase of a qualified account.   Click here to get the IRS Gold Loophole Report now Today's Top Stories SoundHound's AI Growth Story Is Just Getting Started By Gabriel Osorio-Mazilli  |  June 16, 2025 09:22 AM 10 Cheap Stocks Ready to Explode  (Ad) By TradingTips 2 Reasons Adobe Stock Is Ready to Rally This Year By Thomas Hughes  |  June 16, 2025 07:29 AM Micron Joins Latest $200 Billion United States Investment By Gabriel Osorio-Mazilli  |  June 16, 2025 07:20 AM Everyone's watching Nvidia right now. Here's why I'm excited.  (Ad) By Timothy Sykes 4 Buy-and-Hold-Forever Stocks Available at a Bargain By Nathan Reiff  |  June 16, 2025 07:15 AM AMD Accelerates Stack Development: Share Price to Follow By Thomas Hughes  |  June 16, 2025 07:04 AM Quick Links Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Screener Calculators Premium Reports Buy Stock REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (ad) Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).   Click here for the names of our three top stocks to own this year (no purchase necessary). Your Watchlist Manage Your Watchlist and Monitor Your Portfolio   Apple Inc. (AAPL) (6/16) Apple (AAPL) Faces New EU Charges Over Digital Markets Act Violations (gurufocus.com) (6/16) Harvest Announces Harvest Apple Enhanced High Income Shares ETF listing on the TSX (financialpost.com) (6/16) Harvest Announces Harvest Apple Enhanced High Income Shares ETF listing on the TSX (businesswire.com) (6/16) My Top 5 AI Stocks to Buy Before the Second Half (fool.com) (6/16) 1 Unstoppable Stock That Could Join the $1 Trillion Club Alongside Nvidia, Apple, Amazon, Microsoft, and More (fool.com)   Amazon.com, Inc. (AMZN) (6/16) Roku Stock Soars. Why a Team-Up With Amazon Is Giving It a Boost. (barrons.com) (6/16) Amazon (AMZN) and Walmart Explore Stablecoin Possibilities | AMZN Stock News (gurufocus.com) (6/16) Amazon (AMZN) Expands CTV Advertising with New Integration | AMZN Stock News (gurufocus.com) (6/16) Amazon Commits $13 Billion To Expand Australia's AI Data Center Infrastructure (benzinga.com) (6/16) 2 No-Brainer Warren Buffett Stocks to Buy With $1,000 Right Now (fool.com)   Alphabet Inc. (GOOGL) Alphabet Inc. (NASDAQ:GOOGL) declared a quarterly dividend on Wednesday, April 23rd. Stockholders of record on Monday, June 9th will be given a dividend of 0.21 per share by the information services provider on Monday, June 16th. This represents a $0.84 annualized dividend and a dividend yield of 0.48%. The ex-dividend date of this dividend is Monday, June 9th. This is a 5.0% increase from Alphabet's previous quarterly dividend of $0.20. (6/16) Aries Wealth Management Increases Holdings in Alphabet Inc. (NASDAQ:GOOGL) (marketbeat.com) (6/16) Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by Ritholtz Wealth Management (marketbeat.com) (6/15) 2 Artificial Intelligence (AI) Cloud Stocks to Buy in June (fool.com) (6/14) Exclusive-Google, Scale AI's largest customer, plans split after Meta deal, sources say (channelnewsasia.com) (6/14) 3 Magnificent S&P 500 Dividend Stocks Down 15% to 65% to Buy and Hold Forever (fool.com)   Meta Platforms, Inc. (META) Meta Platforms, Inc. (NASDAQ:META) announced a quarterly dividend on Thursday, May 29th. Stockholders of record on Monday, June 16th will be given a dividend of 0.525 per share by the social networking company on Thursday, June 26th. This represents a $2.10 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date is Monday, June 16th. (6/16) Meta Platforms to 'unlock new business with AI' - Oppenheimer raises price target (investing.com) (6/16) WhatsApp's ad-free days are over as Meta begins monetization push (invezz.com) (6/16) WhatsApp's ad-free days are over as Meta begins monetization push (invezz.com) (6/16) Meta is finally bringing ads to WhatsApp (cnbc.com) (6/16) Term Sheet Next: How Facebook's former chief revenue officer is coaching the next generation of startup founders (fortune.com)   Microsoft Co. (MSFT) (6/16) Microsoft Announces 'Data Guardian' for European Operations (investopedia.com) (6/16) Microsoft lays out data protection plans for European cloud customers (msn.com) (6/16) Microsoft lays out data protection plans for European cloud customers (reuters.com) (6/16) Google, Microsoft, Elon Musk's xAI Reportedly Cut Ties With Scale AI After Mark Zuckerberg's Meta Buys Stake (benzinga.com) (6/16) Cardiff Park Advisors LLC Sells 1,803 Shares of Microsoft Co. (NASDAQ:MSFT) (marketbeat.com) Manage Your Watchlist Analysts' Upgrades AAON (NASDAQ:AAON) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $95.00 price target on the stock. This represents a 27.3% upside from the current price of $74.66. Cable One (NYSE:CABO) was upgraded by analysts at BNP Paribas Exane from an "underperform" rating to a "neutral" rating. They now have a $125.00 price target on the stock. This represents a 5.9% downside from the current price of $132.80. Celanese (NYSE:CE) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $66.00 price target on the stock, up previously from $45.00. This represents a 19.9% upside from the current price of $55.06. Celsius (NASDAQ:CELH) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $55.00 price target on the stock, up previously from $37.00. This represents a 24.8% upside from the current price of $44.06. Cisco Systems (NASDAQ:CSCO) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $73.00 price target on the stock. This represents a 11.7% upside from the current price of $65.36. Freeport-McMoRan (NYSE:FCX) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $48.00 price target on the stock, up previously from $43.00. This represents a 13.7% upside from the current price of $42.20. Hudson Technologies (NASDAQ:HDSN) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $9.00 price target on the stock. This represents a 15.9% upside from the current price of $7.77. Incyte (NASDAQ:INCY) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $107.00 price target on the stock. This represents a 50.9% upside from the current price of $70.91. Aerovate Therapeutics (NASDAQ:JBIO) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $14.00 price target on the stock. This represents a 96.6% upside from the current price of $7.12. Phibro Animal Health (NASDAQ:PAHC) was upgraded by analysts at BNP Paribas Exane from an "underperform" rating to a "neutral" rating. They now have a $24.00 price target on the stock. This represents a 4.0% downside from the current price of $25.00. Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $2.00 price target on the stock. This represents a 136.4% upside from the current price of $0.85. Smurfit Westrock (NYSE:SW) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $55.00 price target on the stock, up previously from $44.00. This represents a 26.2% upside from the current price of $43.59. Upexi (NASDAQ:UPXI) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock. This represents a 58.1% upside from the current price of $10.12. UroGen Pharma (NASDAQ:URGN) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $50.00 price target on the stock. This represents a 256.5% upside from the current price of $14.03. Wix.com (NASDAQ:WIX) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $216.00 price target on the stock, up previously from $173.00. This represents a 37.9% upside from the current price of $156.63. View More Upgrades The 402 Dividend Achievers for 2025 (ad) The 2025 Dividend Achievers List 📈 Discover more than 400 companies that have increased their dividends for 10 straight years. This FREE report reveals stocks that are committed to rewarding you and helping you passively boost your income.   Don't miss this valuable opportunity to build a stronger portfolio. Analysts' Downgrades Angi (NASDAQ:ANGI) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.The current price is $15.26. CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.The current price is $149.92. Packaging Co. of America (NYSE:PKG) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $205.00 price target on the stock, down previously from $245.00. This represents a 7.8% upside from the current price of $190.25. PROS (NYSE:PRO) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $18.00 price target on the stock, down previously from $27.00. This represents a 14.9% upside from the current price of $15.67. Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $36.00 price target on the stock. This represents a 84.7% upside from the current price of $19.50. Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at HC Wainwright from a "neutral" rating to a "sell" rating.The current price is $19.50. Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $70.00 price target on the stock. This represents a 259.0% upside from the current price of $19.50. Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.The current price is $19.50. View More Downgrades A new rule goes live in July — and the banks are quietly cashing in (ad) A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.   To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how Analysts' New Coverage Abbott Laboratories (NYSE:ABT) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $143.00 price target on the stock. This represents a 5.0% upside from the current price of $136.21. Allegro MicroSystems (NASDAQ:ALGM) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $38.00 price target on the stock. This represents a 23.7% upside from the current price of $30.72. Alphatec (NASDAQ:ATEC) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $18.00 price target on the stock. This represents a 62.0% upside from the current price of $11.11. Beta Bionics (NASDAQ:BBNX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $26.00 price target on the stock. This represents a 34.2% upside from the current price of $19.37. Boston Scientific (NYSE:BSX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $118.00 price target on the stock. This represents a 15.7% upside from the current price of $101.96. Conagra Brands (NYSE:CAG) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $22.00 price target on the stock. This represents a 2.1% upside from the current price of $21.55. CoStar Group (NASDAQ:CSGP) is now covered by analysts at Stephens. They set an "overweight" rating and a $105.00 price target on the stock. This represents a 27.6% upside from the current price of $82.29. Janover (NASDAQ:DFDV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $45.00 price target on the stock. This represents a 48.4% upside from the current price of $30.32. DexCom (NASDAQ:DXCM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $102.00 price target on the stock. This represents a 22.2% upside from the current price of $83.49. Enliven Therapeutics (NASDAQ:ELVN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $37.00 price target on the stock. This represents a 58.2% upside from the current price of $23.39. Freshpet (NASDAQ:FRPT) is now covered by analysts at UBS Group AG. They set a "sell" rating and a $65.00 price target on the stock. This represents a 11.3% downside from the current price of $73.28. Hinge Health (NYSE:HNGE) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 15.8% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $50.00 price target on the stock. This represents a 37.9% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $46.00 price target on the stock. This represents a 26.9% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $41.00 price target on the stock. This represents a 13.1% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Raymond James. They set an "outperform" rating and a $45.00 price target on the stock. This represents a 24.1% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $45.00 price target on the stock. This represents a 24.1% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $48.00 price target on the stock. This represents a 32.4% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $48.00 price target on the stock. This represents a 32.4% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $52.00 price target on the stock. This represents a 43.4% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $45.00 price target on the stock. This represents a 24.1% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $47.00 price target on the stock. This represents a 29.6% upside from the current price of $36.26. Hinge Health (NYSE:HNGE) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $43.00 price target on the stock. This represents a 18.6% upside from the current price of $36.26. Hudson Pacific Properties (NYSE:HPP) is now covered by analysts at Odeon Capital Group LLC. They set a "buy" rating and a $5.00 price target on the stock. This represents a 73.9% upside from the current price of $2.88. Inogen (NASDAQ:INGN) is now covered by analysts at B. Riley. They set a "buy" rating and a $14.00 price target on the stock. This represents a 102.9% upside from the current price of $6.90. Knife River (NYSE:KNF) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $129.00 price target on the stock. This represents a 54.0% upside from the current price of $83.75. Medtronic (NYSE:MDT) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $110.00 price target on the stock. This represents a 24.2% upside from the current price of $88.56. McCormick & Company, Incorporated (NYSE:MKC) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $83.00 price target on the stock. This represents a 11.3% upside from the current price of $74.57. Martin Marietta Materials (NYSE:MLM) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating and a $515.00 price target on the stock. This represents a 5.5% downside from the current price of $545.09. MNTN (NYSE:MNTN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $28.00 price target on the stock. This represents a 32.8% upside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Citizens Jmp. They set a "mkt outperform" rating and a $23.00 price target on the stock. This represents a 9.1% upside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 28.1% upside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $20.00 price target on the stock. This represents a 5.1% downside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Susquehanna. They set a "positive" rating and a $38.00 price target on the stock. This represents a 80.3% upside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 28.1% upside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Loop Capital. They set a "buy" rating and a $29.00 price target on the stock. This represents a 37.6% upside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $22.00 price target on the stock. This represents a 4.4% upside from the current price of $21.08. MNTN (NYSE:MNTN) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $25.00 price target on the stock. This represents a 18.6% upside from the current price of $21.08. Procore Technologies (NYSE:PCOR) is now covered by analysts at Arete. They set a "buy" rating and a $91.00 price target on the stock. This represents a 39.3% upside from the current price of $65.35. Insulet (NASDAQ:PODD) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $365.00 price target on the stock. This represents a 17.9% upside from the current price of $309.49. Sweetgreen (NYSE:SG) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $19.00 price target on the stock. This represents a 47.1% upside from the current price of $12.92. Signet Jewelers (NYSE:SIG) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $102.00 price target on the stock. This represents a 27.3% upside from the current price of $80.15. Talos Energy (NYSE:TALO) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $14.00 price target on the stock. This represents a 52.4% upside from the current price of $9.19. Tandem Diabetes Care (NASDAQ:TNDM) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $24.00 price target on the stock. This represents a 15.1% upside from the current price of $20.85. ZenaTech (NASDAQ:ZENA) is now covered by analysts at Maxim Group. They set a "buy" rating and a $9.00 price target on the stock. This represents a 72.6% upside from the current price of $5.21. View More New Coverage Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Earnings Conference Calls Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Stock Splits Unusual Options Volume Unusual Trading Volume Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. Upgrade Now Manage Your Watchlist View and add up to five holdings to your watchlist. View My Portfolio Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. Join Now Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2025 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: 7 Stocks Set to Win Big Under Trump's America First Agenda 🚀 (Click to Opt-In)

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: